Myeloid-derived suppressor cells in ovarian cancer: friend or foe?

Although previous decades contributed to major progress in targeted therapy of many malignancies, the treatment of gynaecological cancers remains a challenging task. In the evidence of rising cancer mortality, the search for new methods of treatment is a dire need. Exploring the mechanisms of intera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cent Eur J Immunol
Autors principals: Walankiewicz, Monika, Grywalska, Ewelina, Polak, Grzegorz, Kotarski, Jan, Siwicka-Gieroba, Dorota J., Roliński, Jacek
Format: Artigo
Idioma:Inglês
Publicat: Polish Society of Experimental and Clinical Immunology 2017
Matèries:
Review Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820985/
https://ncbi.nlm.nih.gov/pubmed/29472817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2017.72823
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars